MAR 05, 2019 8:50 AM PST

Fasting to Fight Cancer - How It Works

WRITTEN BY: Kara Marker

Human ancestors often resorted to fasting when stricken with an illness as a way to prevent infectious or abnormally growing cells from circulating the blood stream and inhabiting other parts of the body. Two new studies find that our ancestors may have been on to something - restricting calories in mice has shown to greatly decrease tumor volumes in subjects receiving chemotherapy.
Credit: vitals.lifehacker.com
Although the scientists are not quite sure yet how fasting leads to a better immune response to cancerous cells, the findings from their recent studies show that fasting recruits more cancer-killing, cytotoxic T lymphocytes to the scene of the cancer crime. Tumors are often guilty of producing immunosuppressive molecules that help them “hide” from the immune system, but new studies in mice suggest that the game of hide-and-seek could soon be over.

One of the studies published in the journal Cancer Cell comes from the lab of Valter Longo, Stefano Di Biase, and Changhan Lee from the University of Southern California (USC). Their method of mimicking fasting in their mouse subject was to restrict their diet to low sugar, low protein, high fat, and low-calorie foods to meet a balance of challenging the cancer cells without starving the healthy cells. After collecting data for over six weeks from mice ridden with breast or skin cancers, researchers saw both the influx of cytotoxic T lymphocytes as well as the tumors of mice receiving both chemotherapy and the restricted diet shrinking to less than half of the volume of the tumors in mice receiving only chemotherapy.

“T cells are essential for the toxicity of the fasting plus chemotherapy to cancer cells,” Longo said. He and his team discovered that the fasting and chemotherapy combination brings out cytotoxic T lymphocytes by reducing levels of an enzyme called heme oxygenase-1. Normally at high levels in tumor cells, heme oxygenase-1 has anti-inflammatory functions and has been implicated in carcinogenesis and tumor progression in previous studies. 

The second Cancer Cell study was conducted by several scientists from INSERM and the Centre de Recherche des Cordeliers in France. Instead of mimicking fasting with diet restriction, the researchers used drugs called caloric restriction mimetics. They “selectively trigger” the induction of the same biochemical environment that stems from actual fasting without actually leading to any weight loss. The mimetic drug they used was called hydroxycitrate, and they tested the drug in mice with lung and breast cancers in a similar fashion to the other study.

The calorie restriction mimetics technique proved to be equally as effective as the diet restriction approach: researchers saw a reduction of both tumor size and total number of tumors. 

Coming up next in the realm of fasting to fight cancer is making sure the trend the researchers saw in mice in cancer will be the same in humans. And, as always, with human trials comes the issue of safety - which Longo is already working on proving. Cancer cells gotta eat too. Let’s starve them out! 
 

 


Sources: Cell Press, Journal of Biomedical Science
 

 

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 14, 2020
Cancer
MiR-107 and Its Role in Radiosensitivity in Prostate Cancer
SEP 14, 2020
MiR-107 and Its Role in Radiosensitivity in Prostate Cancer
It is often unknown whether a patient will respond to a treatment until it is in full swing. New research is attempting ...
SEP 22, 2020
Cardiology
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
SEP 22, 2020
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
Cancer therapies have come quite far, with several options available for many cancers. An issue that has plagued many of ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
OCT 09, 2020
Genetics & Genomics
Using CRISPR to Destroy Cancer Cells
OCT 09, 2020
Using CRISPR to Destroy Cancer Cells
Researchers have developed a way to selectively target certain cancer cells with CRISPR.
OCT 26, 2020
Cancer
Attacking leukemia trojan horse style
OCT 26, 2020
Attacking leukemia trojan horse style
Researchers from the Max Planck Institute of Biochemistry have developed a new approach to targeting leukemic stem cells ...
NOV 23, 2020
Cancer
Platelets May Protect Cancer Against PD-1 Therapies
NOV 23, 2020
Platelets May Protect Cancer Against PD-1 Therapies
One of cancer’s greatest tools is its ability to manipulate the immune system. Many cancer therapies have arisen t ...
Loading Comments...